Abbott Laboratories ABT
NYSE ABT
$106.03 +0.51 (+0.48%)
As of: Sep 9, 2026 · 11:55 AM EDT

Abbott Laboratories (ABT) Capital Expenditures (QoQ) (2009 - 2026)

Analysis

Abbott Laboratories (ABT) Capital Expenditures (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 184.79 Bn 179.19 Bn 7.27 Bn
2 Intuitive Surgical 124.38 Bn 119.16 Bn 1.96 Bn
3 Medtronic 118.45 Bn 109.63 Bn 6.34 Bn
4 Stryker 105.32 Bn 101.84 Bn 4.50 Bn
5 Boston Scientific 66.71 Bn 66.17 Bn 3.85 Bn
6 Edwards Lifesciences 49.81 Bn 45.56 Bn 1.35 Bn
7 Alcon 34.03 Bn 32.58 Bn 1.68 Bn
8 Dexcom 32.35 Bn 30.40 Bn 830.00 Mn
9 Steris 21.17 Bn 20.68 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.27 Bn 17.86 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.56%
Mar 31, 2026 -42.09%
Dec 31, 2025 38.91%
Sep 30, 2025 -1.20%
Jun 30, 2025 3.72%
Mar 31, 2025 -32.78%
Dec 31, 2024 29.50%
Sep 30, 2024 4.32%
Jun 30, 2024 33.92%
Mar 31, 2024 -47.28%
Dec 31, 2023 34.82%
Sep 30, 2023 10.45%
Jun 30, 2023 33.42%
Mar 31, 2023 -37.70%
Dec 31, 2022 30.62%
Sep 30, 2022 23.22%
Jun 30, 2022 18.07%
Mar 31, 2022 -47.72%
Dec 31, 2021 33.19%
Sep 30, 2021 11.62%